Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.
about
New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney DiseaseVitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirinMicroRNA-155 and Anti-Müllerian Hormone: New Potential Markers of Subfertility in Men with Chronic Kidney DiseaseVitamin D status is independently associated with plasma glutathione and cysteine thiol/disulphide redox status in adultsThe influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study.Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study.Neutrophil Gelatinase-Associated Lipocalin, Fibroblast Growth Factor 23, and Soluble Klotho in Long-Term Kidney Donors.Selective vitamin D receptor activation as anti-inflammatory target in chronic kidney disease.Vitamin D and diabetes mellitus: Causal or casual association?Which vitamin D in CKD-MBD? The time of burning questions.Oral paricalcitol versus oral calcitriol in continuous ambulatory peritoneal dialysis patients with secondary hyperparathyroidism.Role of Vitamin D in Maintaining Renal Epithelial Barrier Function in Uremic Conditions.Effect of paricalcitol on pancreatic oxidative stress, inflammatory markers, and glycemic status in diabetic rats.Evaluation of vitamin D status and its correlation with oxidative stress markers in women with polycystic ovary syndrome.Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study.Vitamin D receptor: A novel therapeutic target for kidney diseases.Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria.Daily intake of vitamin D- or calcium-vitamin D-fortified Persian yogurt drink (doogh) attenuates diabetes-induced oxidative stress: evidence for antioxidative properties of vitamin D.Paricalcitol may improve oxidative DNA damage on experimental amikacin-induced nephrotoxicity model.Non-mercaptalbumin, Oxidized Form of Serum Albumin, Significantly Associated with Renal Function and Anemia in Chronic Kidney Disease PatientsRedox State of Human Serum Albumin and Inflammatory Biomarkers in Hemodialysis Patients with Secondary Hyperparathyroidism During Oral Calcitriol Supplementation for Vitamin D
P2860
Q26739475-CC4E599E-2A39-45A6-991A-B237EBF284D6Q26784321-25085315-7B97-479A-911C-655BA243F167Q33652408-7DDFC465-7111-4EEF-AE03-6AD071692836Q33969236-9437C330-0DE8-4A57-A702-D3940FBF890BQ34059805-13CDCD94-E2C9-4D3D-B09C-938A4D3CFA15Q36189171-F84D048A-AEC7-470A-80DB-C7715087F454Q37439484-A567828A-1E15-43BD-9078-79D702D7091CQ37553481-E25B1CA0-C726-43C3-9C90-C610B96B23A4Q38773655-476C5534-5906-4C28-8125-624D8EA848EBQ42562972-C7F51C30-9394-4525-8499-ED7FE63E29E1Q44125599-B5C77C23-CA2B-4E81-AE43-4FD8EDDA26A7Q46251808-F75D7A8D-CCC6-4093-A4D4-A174AEBF9840Q46497245-DAF4A6ED-42B1-47F2-A678-5DCDBCBB89ECQ47137393-B081FB08-74E2-4CF6-9650-8AAFBC354F31Q48242270-D28D8910-DF7E-4408-8BF4-8B12B89EAD9CQ49985993-51658DF7-AAC4-446A-8E17-7323DC4D9A4EQ50433834-4EAD85B9-FAAC-427F-AAA7-F1C3C1674595Q50856187-C0AB022B-091F-4660-A573-CB41B4B45176Q53146106-9FC3BEC1-A3B0-4A12-BE25-580A7DC95062Q59127057-CB03FE16-18FF-4335-8A6A-C07A31206F8EQ59132558-AC2D2D3E-4AC1-44D7-B25B-CDAD1292D979
P2860
Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.
@ast
Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.
@en
Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.
@nl
type
label
Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.
@ast
Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.
@en
Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.
@nl
prefLabel
Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.
@ast
Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.
@en
Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.
@nl
P2093
P2860
P356
P1433
P1476
Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.
@en
P2093
Angel L M de Francisco
Javier Santos
Manuel Arias
María Jesús Izquierdo
Mónica Cavia
Pedro Abaigar
Pilar Muñiz
P2860
P356
10.1186/1471-2369-13-159
P577
2012-11-27T00:00:00Z